Activity Description:

This Grand Rounds session reviews contemporary, evidence-based lipid management in patients with established coronary artery disease (CAD) and type 2 diabetes melitus-individuals classified as very high risk for recurrent atherosclerotic cardiovascular events. Emphasis will be placed on current recommendations, including LDL-C targets, intensification strategies beyond statin therapy, and management of residual cardiovascular risk to reduce morbidity and mortality. 

Target Audience: 

This course is designed for hospitalists, nurse practitioners, physician assistants, advance practice nurses, registered nurses, allied health professionals, physicians and residents.

Learning Objectives:

• Explain why patients with CAD and type 2 diabetes are classified as very high risk for atherosclerotic cardiovascular events.
• Implement guideline directed pharmacological approach to lipid lowering, including non-pharmacological therapies.
• Integrate management of residual cardiometabolic risk factors alongside lipid optimization to reduce recurrent cardiovascular events.

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare Gulf Coast Division. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence all parties in control of content are required to disclose all conflicts of interest with ACCME defined ineligible companies. None of the planners, faculty, and those in control of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.